메뉴 건너뛰기




Volumn 118, Issue 6, 2006, Pages 1320-1326

Smallpox vaccines: Past, present, and future

Author keywords

immunization; monkeypox; Poxvirus; vaccination; variola

Indexed keywords

ACAM 3000; ALKYLATING AGENT; ANTIMETABOLITE; CHLORTETRACYCLINE; CORTICOSTEROID; DIHYDROSTREPTOMYCIN; DNA VACCINE; LANCY VAXINA; LC 16M8; LIVE VACCINE; NEOMYCIN; POLYMYXIN B; SMALLPOX VACCINE;

EID: 33845204083     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.09.037     Document Type: Article
Times cited : (107)

References (40)
  • 1
    • 33845222889 scopus 로고    scopus 로고
    • The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox, Geneva, December 1979. Geneva: World Health Organization; 1980.
  • 3
  • 4
    • 21144439209 scopus 로고    scopus 로고
    • Adventitious agents and smallpox vaccine in strategic national stockpile
    • Murphy F.A., and Osburn B.I. Adventitious agents and smallpox vaccine in strategic national stockpile. Emerg Infect Dis 11 (2005) 1086-1089
    • (2005) Emerg Infect Dis , vol.11 , pp. 1086-1089
    • Murphy, F.A.1    Osburn, B.I.2
  • 7
    • 0033538314 scopus 로고    scopus 로고
    • Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
    • Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281 (1999) 2127-2137
    • (1999) JAMA , vol.281 , pp. 2127-2137
    • Henderson, D.A.1    Inglesby, T.V.2    Bartlett, J.G.3    Ascher, M.S.4    Eitzen, E.5    Jahrling, P.B.6
  • 11
    • 24644449093 scopus 로고    scopus 로고
    • Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial
    • Kim S.H., Yeo S.G., Jang H.C., Park W.B., Lee C.S., Lee K.D., et al. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial. J Infect Dis 192 (2005) 1066-1070
    • (2005) J Infect Dis , vol.192 , pp. 1066-1070
    • Kim, S.H.1    Yeo, S.G.2    Jang, H.C.3    Park, W.B.4    Lee, C.S.5    Lee, K.D.6
  • 12
    • 28844475184 scopus 로고    scopus 로고
    • Adverse events associated with smallpox vaccination in the United States, January-October 2003
    • Casey C.G., Iskander J.K., Roper M.H., Mast E.E., Wen X.J., Torok T.J., et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 294 (2005) 2734-2743
    • (2005) JAMA , vol.294 , pp. 2734-2743
    • Casey, C.G.1    Iskander, J.K.2    Roper, M.H.3    Mast, E.E.4    Wen, X.J.5    Torok, T.J.6
  • 13
    • 0038167809 scopus 로고    scopus 로고
    • US military smallpox vaccination program experience
    • Grabenstein J.D., and Winkenwerder Jr. W. US military smallpox vaccination program experience. JAMA 289 (2003) 3278-3282
    • (2003) JAMA , vol.289 , pp. 3278-3282
    • Grabenstein, J.D.1    Winkenwerder Jr., W.2
  • 15
    • 33845197125 scopus 로고    scopus 로고
    • Winkenwerder W Jr. Smallpox vaccination safety summary. Available at: http://www.smallpox.army.mil/event/SPSafetySum.asp. Accessed October 23, 2006.
  • 16
    • 4444307123 scopus 로고    scopus 로고
    • Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial
    • Talbot T.R., Stapleton J.T., Brady R.C., Winokur P.L., Bernstein D.I., Germanson T., et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 292 (2004) 1205-1212
    • (2004) JAMA , vol.292 , pp. 1205-1212
    • Talbot, T.R.1    Stapleton, J.T.2    Brady, R.C.3    Winokur, P.L.4    Bernstein, D.I.5    Germanson, T.6
  • 17
    • 0242495755 scopus 로고    scopus 로고
    • Cutting edge: long-term B cell memory in humans after smallpox vaccination
    • Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., and Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 (2003) 4969-4973
    • (2003) J Immunol , vol.171 , pp. 4969-4973
    • Crotty, S.1    Felgner, P.2    Davies, H.3    Glidewell, J.4    Villarreal, L.5    Ahmed, R.6
  • 18
    • 15244351966 scopus 로고    scopus 로고
    • Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8
    • Kidokoro M., Tashiro M., and Shida H. Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8. Proc Natl Acad Sci U S A 102 (2005) 4152-4157
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 4152-4157
    • Kidokoro, M.1    Tashiro, M.2    Shida, H.3
  • 19
    • 33645232533 scopus 로고    scopus 로고
    • Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge
    • Empig C., Kenner J.R., Perret-Gentil M., Youree B.E., Bell E., Chen A., et al. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. Vaccine 24 (2006) 3686-3694
    • (2006) Vaccine , vol.24 , pp. 3686-3694
    • Empig, C.1    Kenner, J.R.2    Perret-Gentil, M.3    Youree, B.E.4    Bell, E.5    Chen, A.6
  • 20
    • 13144283663 scopus 로고    scopus 로고
    • Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial
    • Greenberg R.N., Kennedy J.S., Clanton D.J., Plummer E.A., Hague L., Cruz J., et al. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. Lancet 365 (2005) 398-409
    • (2005) Lancet , vol.365 , pp. 398-409
    • Greenberg, R.N.1    Kennedy, J.S.2    Clanton, D.J.3    Plummer, E.A.4    Hague, L.5    Cruz, J.6
  • 21
    • 7444242665 scopus 로고    scopus 로고
    • ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain): a second-generation smallpox vaccine for biological defense
    • Monath T.P., Caldwell J.R., Mundt W., Fusco J., Johnson C.S., Buller M., et al. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain): a second-generation smallpox vaccine for biological defense. Int J Infect Dis 8 suppl 2 (2004) S31-S44
    • (2004) Int J Infect Dis , vol.8 , Issue.SUPPL. 2
    • Monath, T.P.1    Caldwell, J.R.2    Mundt, W.3    Fusco, J.4    Johnson, C.S.5    Buller, M.6
  • 22
    • 0141573164 scopus 로고    scopus 로고
    • Clonal vaccinia virus grown in cell culture as a new smallpox vaccine
    • Weltzin R., Liu J., Pugachev K.V., Myers G.A., Coughlin B., Blum P.S., et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med 9 (2003) 1125-1130
    • (2003) Nat Med , vol.9 , pp. 1125-1130
    • Weltzin, R.1    Liu, J.2    Pugachev, K.V.3    Myers, G.A.4    Coughlin, B.5    Blum, P.S.6
  • 23
    • 2942693560 scopus 로고    scopus 로고
    • Modified vaccinia Ankara: potential as an alternative smallpox vaccine
    • McCurdy L.H., Larkin B.D., Martin J.E., and Graham B.S. Modified vaccinia Ankara: potential as an alternative smallpox vaccine. Clin Infect Dis 38 (2004) 1749-1753
    • (2004) Clin Infect Dis , vol.38 , pp. 1749-1753
    • McCurdy, L.H.1    Larkin, B.D.2    Martin, J.E.3    Graham, B.S.4
  • 24
    • 0016400312 scopus 로고
    • [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's translation)]
    • Stickl H., Hochstein-Mintzel V., Mayr A., Huber H.C., Schafer H., and Holzner A. [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's translation)]. Dtsch Med Wochenschr 99 (1974) 2386-2392
    • (1974) Dtsch Med Wochenschr , vol.99 , pp. 2386-2392
    • Stickl, H.1    Hochstein-Mintzel, V.2    Mayr, A.3    Huber, H.C.4    Schafer, H.5    Holzner, A.6
  • 25
    • 12144290086 scopus 로고    scopus 로고
    • Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
    • Earl P.L., Americo J.L., Wyatt L.S., Eller L.A., Whitbeck J.C., Cohen G.H., et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428 (2004) 182-185
    • (2004) Nature , vol.428 , pp. 182-185
    • Earl, P.L.1    Americo, J.L.2    Wyatt, L.S.3    Eller, L.A.4    Whitbeck, J.C.5    Cohen, G.H.6
  • 26
    • 23844526887 scopus 로고    scopus 로고
    • Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model
    • Meseda C.A., Garcia A.D., Kumar A., Mayer A.E., Manischewitz J., King L.R., et al. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Virology 339 (2005) 164-175
    • (2005) Virology , vol.339 , pp. 164-175
    • Meseda, C.A.1    Garcia, A.D.2    Kumar, A.3    Mayer, A.E.4    Manischewitz, J.5    King, L.R.6
  • 27
    • 7644238902 scopus 로고    scopus 로고
    • Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4
    • McCurdy L.H., Rutigliano J.A., Johnson T.R., Chen M., and Graham B.S. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4. J Virol 78 (2004) 12471-12479
    • (2004) J Virol , vol.78 , pp. 12471-12479
    • McCurdy, L.H.1    Rutigliano, J.A.2    Johnson, T.R.3    Chen, M.4    Graham, B.S.5
  • 28
    • 32844466244 scopus 로고    scopus 로고
    • Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
    • Vollmar J., Arndtz N., Eckl K.M., Thomsen T., Petzold B., Mateo L., et al. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine 24 (2006) 2065-2070
    • (2006) Vaccine , vol.24 , pp. 2065-2070
    • Vollmar, J.1    Arndtz, N.2    Eckl, K.M.3    Thomsen, T.4    Petzold, B.5    Mateo, L.6
  • 29
    • 1842532903 scopus 로고    scopus 로고
    • Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge
    • Wyatt L.S., Earl P.L., Eller L.A., and Moss B. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci U S A 101 (2004) 4590-4595
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 4590-4595
    • Wyatt, L.S.1    Earl, P.L.2    Eller, L.A.3    Moss, B.4
  • 30
    • 19944430572 scopus 로고    scopus 로고
    • Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge
    • Edghill-Smith Y., Bray M., Whitehouse C.A., Miller D., Mucker E., Manischewitz J., et al. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J Infect Dis 191 (2005) 372-381
    • (2005) J Infect Dis , vol.191 , pp. 372-381
    • Edghill-Smith, Y.1    Bray, M.2    Whitehouse, C.A.3    Miller, D.4    Mucker, E.5    Manischewitz, J.6
  • 31
    • 0036310570 scopus 로고    scopus 로고
    • Immunogenicity and safety of defective vaccinia virus Lister: comparison with modified vaccinia virus Ankara
    • Ober B.T., Bruhl P., Schmidt M., Wieser V., Gritschenberger W., Coulibaly S., et al. Immunogenicity and safety of defective vaccinia virus Lister: comparison with modified vaccinia virus Ankara. J Virol 76 (2002) 7713-7723
    • (2002) J Virol , vol.76 , pp. 7713-7723
    • Ober, B.T.1    Bruhl, P.2    Schmidt, M.3    Wieser, V.4    Gritschenberger, W.5    Coulibaly, S.6
  • 33
    • 33747149959 scopus 로고    scopus 로고
    • Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy
    • Otero M., Calarota S.A., Dai A., De Groot A.S., Boyer J.D., and Weiner D.B. Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy. Vaccine 24 (2006) 4461-4470
    • (2006) Vaccine , vol.24 , pp. 4461-4470
    • Otero, M.1    Calarota, S.A.2    Dai, A.3    De Groot, A.S.4    Boyer, J.D.5    Weiner, D.B.6
  • 34
    • 4544371098 scopus 로고    scopus 로고
    • Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions
    • Fogg C., Lustig S., Whitbeck J.C., Eisenberg R.J., Cohen G.H., and Moss B. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. J Virol 78 (2004) 10230-10237
    • (2004) J Virol , vol.78 , pp. 10230-10237
    • Fogg, C.1    Lustig, S.2    Whitbeck, J.C.3    Eisenberg, R.J.4    Cohen, G.H.5    Moss, B.6
  • 35
    • 0037205534 scopus 로고    scopus 로고
    • 21 CFR Parts 314 and 601. Federal Register May 31, 2002;67(105):37988-98.
  • 36
    • 23944512221 scopus 로고    scopus 로고
    • Virulence differences between monkeypox virus isolates from West Africa and the Congo basin
    • Chen N., Li G., Liszewski M.K., Atkinson J.P., Jahrling P.B., Feng Z., et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 340 (2005) 46-63
    • (2005) Virology , vol.340 , pp. 46-63
    • Chen, N.1    Li, G.2    Liszewski, M.K.3    Atkinson, J.P.4    Jahrling, P.B.5    Feng, Z.6
  • 38
    • 33845211430 scopus 로고    scopus 로고
    • 8th reports of the International Committee on Taxonomy of viruses. Available at: http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/index.htm. Accessed October 23, 2006.
  • 39
    • 33845229082 scopus 로고    scopus 로고
    • Smallpox vaccine dried, calf lymph type. Available at: http://www.fda.gov/CBER/label/smalwye070303LB.pdf. Accessed October 23, 2006.
  • 40
    • 33845204121 scopus 로고    scopus 로고
    • ® challenge in vaccinia-naive and vaccinia-immune individuals. Vaccine 2006. In press.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.